Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer.

Chen, Long Xia; Ni, Xiao Ling; Zhang, Heng; Wu, Min; Liu, Jing; Xu, Shan; Yang, Ling Lin; Fu, Shao Zhi; Wu, Jingbo

Chen, Long Xia; Ni, Xiao Ling; Zhang, Heng; Wu, Min; Liu, Jing; Xu, Shan; Yang, Ling Lin; Fu, Shao Zhi; Wu, Jingbo.

Afiliación

Chen LX; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Ni XL; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Zhang H; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Wu M; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Liu J; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Xu S; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Yang LL; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Fu SZ; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Wu J; Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.

Int J Nanomedicine ; 13: 2463-2476, 2018.

Article en En | MEDLINE | ID: mdl-29719394

Asunto(s)

Antineoplásicos/farmacología; Neoplasias Pulmonares/tratamiento farmacológico; Nanopartículas/administración & dosificación; Talidomida/farmacología; Animales; Antineoplásicos/administración & dosificación; Antineoplásicos/farmacocinética; Línea Celular Tumoral; Sistemas de Liberación de Medicamentos/métodos; Liberación de Fármacos; Humanos; Interacciones Hidrofóbicas e Hidrofílicas; Neoplasias Pulmonares/mortalidad; Neoplasias Pulmonares/patología; Ratones Desnudos; Nanopartículas/química; Tamaño de la Partícula; Poliésteres/química; Polietilenglicoles/química; Tomografía de Emisión de Positrones; Solubilidad; Tasa de Supervivencia; Talidomida/administración & dosificación; Talidomida/farmacocinética; Ensayos Antitumor por Modelo de Xenoinjerto

Palabras clave

MPEG-PCL; lung cancer; nanoparticles; thalidomide

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Talidomida / Nanopartículas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int J Nanomedicine Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google